A recent study discovered that semaglutide, a medication already used in the treatment of type 2 diabetes and weight loss, can significantly reduce asthma attacks by up to 40%. The research analyzed the effects of semaglutide injections in patients suffering from the respiratory disease.
The active ingredient in semaglutide, originally developed to control blood sugar levels, demonstrated unexpected benefits in fighting airway inflammation. Researchers observed a significant improvement in patients who used the medication.
The study suggests that semaglutide may work as a complementary treatment for people with asthma, especially those who do not respond adequately to conventional treatments. The discovery opens new therapeutic possibilities for the disease that affects millions of people worldwide.
